Search Results for: "Other News to Note"
-
Other News To Note
Gilead Sciences Inc. , of Foster City, Calif., said the European Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, recommended approval for Truvada (emtricitabine and tenofovir disoproxil fumarate) in the 25 member states of the European UnionBioWorld Today | Friday, November 19, 2004 -
Other News To Note
The approval follows a positive opinion granted in July by the Committee for Medicinal Products for Human UseBioWorld Today | Friday, October 15, 2004 -
Other News To Note
Amgen Inc. , of Thousand Oaks, Calif., said the European Commission approved expanded marketing authorization for Aranesp (darbepoetin alfa) in the European Union following a positive opinion from the European Committee for Medicinal Products for Human Use in JulyBioWorld International | Wednesday, September 29, 2004 -
Other News To Note
Amgen Inc. , of Thousand Oaks, Calif., said the European Commission approved expanded marketing authorization for Aranesp (darbepoetin alfa) in the European Union following the positive opinion from the European Committee for Medicinal Products for Human Use in JulyBioWorld Today | Wednesday, September 22, 2004 -
Other News To Note
Amgen Inc., of Thousand Oaks, Calif., received a positive opinion from the European Committee for Medicinal Products for Human Use for an expanded marketing authorization of Aranesp (darbepoetin alfa) in the European UnionBioWorld Today | Monday, August 9, 2004 -
Other News To Note
It does not resolve pending governmental investigations and other private litigation related to wholesaler inventory issues and other accounting matters...To that end, the company appointed Mark Pavao its senior vice president of sales and marketingBioWorld Today | Tuesday, August 3, 2004 -
Other News To Note
Amgen Inc., of Thousand Oaks, Calif., said the European Committee for Medicinal Products for Human Use recommended approval of Mimpara (cinacalcet HCl) for secondary hyperparathyroidism in chronic kidney disease patients on dialysis and for treating hypercalcemia in patients with parathyroid carcinomaBioWorld Today | Monday, August 2, 2004 -
Other News To Note
Orbus plans to enter a supply agreement with BioInvent for commercial-grade antibodies once process development and product approval are complete...Licenses in other European countries are expected to be granted over the next 12 monthsBioWorld International | Wednesday, June 30, 2004 -
Other News To Note
In other news, the company said researchers presented Phase II data on GVAX pancreatic cancer vaccine in patients with inoperable metastatic pancreatic cancer at the Lustgarten Foundation for Pancreatic Cancer Research's annual meeting...Licenses in other European countries are expected to be granted over the next 12 months...DOV Pharmaceutical Inc. , of Hackensack, N.J., said the FDA agreed to lift the clinical hold on ocinaplon, the company's anxiolytic, subject to its review of a revised clinicalBioWorld Today | Tuesday, June 29, 2004 -
Other News To Note
Simultaneously, Angiotech agreed to pay $13 million to acquire NeuColl Inc., of Los Gatos, Calif...Three other potential biomarkers were found to be lower in patients' urine with the onset of transplant rejectionBioWorld Today | Friday, June 25, 2004 -
Other News To Note
Biophage is developing anti-inflammatory products for humans and anti-infective products for antibiotic-resistant infections in livestockBioWorld Today | Monday, June 7, 2004 -
Other News To Note
It also has shown high levels of transfection rates of the product in human cells without causing the damage to the cell membrane that occurs with some other productsBioWorld International | Wednesday, October 15, 2003 -
Other News To Note
Genentech also acquired nonexclusive, worldwide rights to diagnostic and small-molecule products for human use based on the same geneBioWorld Today | Friday, August 8, 2003 -
Other News To Note
Charles River said BioLabs is positioned to serve Irish-based multinationals, as well as companies located elsewhere in Europe and the U.S., that develop products for human and animal health marketsBioWorld Today | Tuesday, June 11, 2002 -
Other News To Note
Bio-Technology General develops genetically engineered and other products for human health careBioWorld Today | Thursday, April 25, 2002 -
Other News To Note
Maxygen focuses on creating products for human therapeutics and industrial applicationsBioWorld Today | Monday, February 11, 2002 -
Other News To Note
The expansion will enable Genzyme to produce CTLA4Ig fusion protein in amounts sufficient to supply bulk products for human trials. Geron Corp., of Menlo Park, Calif., and Clontech Laboratories Inc., of Palo Alto, Calif., said the launch of the hTERT-HME1 human mammary epithelial cell line marks the third cell type offered in the Infinity family of telomerase-immortalized cells, cells that express human telomerase reverse transcriptaseBioWorld Today | Wednesday, January 10, 2001 -
Other News To Note
The report is published in the October issue of the British Journal of Surgery. Genome Therapeutics Corp., of Waltham, Mass., and bioMerieux SA, of Lyon, France, will combine to develop, manufacture and sell in vitro diagnostic products for human clinical and industrial applicationsBioWorld Today | Wednesday, October 13, 1999
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.